Background Elderly people in long-term care facilities (LTCF) are at higher risk for (severe)
COVID-19, yet evidence of vaccine effectiveness (VE) in this population is scarce. In …

Elderly care home residents are particularly vulnerable to COVID-19 due to immune-
senescence, pre-existing medical conditions, and the risk of transmission from staff and …

COVID-19 has caused high morbidity and mortality in long-term care facilities (LTCFs)
worldwide. We estimated vaccine effectiveness (VE) among residents and health care …

Background: Long-term care facilities (LTCFs) experienced severe burden from the
Coronavirus 2019 (COVID-19), and vaccination against SARS-CoV-2 is a major issue for …

Background vaccinations for COVID-19 have been prioritised for older people living in care
homes. However, vaccination trials included limited numbers of older people. Aim we aimed …

Introduction Long term care facilities for elderly (LTCFs) in Europe encountered a high
disease burden at the start of the COVID-19 pandemic. Therefore, these facilities were the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
severe disease in unvaccinated long-term care facility (LTCF) residents. Initial booster …

Background SARS‐CoV‐2 vaccination has significantly reduced infection, hospitalization,
and lethality rates among nursing home (NH) residents, but durability of vaccine effects …

Background: It is not known if widespread vaccination can prevent the spread of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in subpopulations at high risk, like …

Objective We aimed to define the epidemiology of COVID-19 outbreaks in aged care
facilities (ACFs) during the postvaccine period, including vaccine effectiveness (VE) for this …